Navigation Links
Welch Allyn Wall/Desk Power Source for Binocular Indirect Ophthalmoscope

ProductsWelch Allyn Wall/Desk Power Source for Binocular Indirect Ophthalmoscope
Company Welch Allyn Medical Products
Item Welch Allyn Wall/Desk Power Source for Binocular Indirect Ophthalmoscope
Features 
  • The portable power pack allows the BIO to go wherever exams take place.
  • Provides up to 60 minutes of continuous on-time and simple plug-in transformer recharging.
  • The indicator lights display power on, low power, and recharging.
  • The rheostat is easy to access, and back clip allows easy portability.
  • Description The Binocular Indirect Ophthalmoscope Power Source provides power to the top of a superior line of ophthalmic instruments. The versatile wall/desk power source can be used on a desk, wall, or on the side of a desk - and wherever you place it. The portable power pack provides power no matter where your exams take place.
    Info Welch Allyn Medical Products
    Customer Service: (800) 535-6663
    Web site: http://www.welchallyn.com/medical/

    Related medicine products :

    1. Welch Allyn PanOptic Ophthalmoscope with Cobalt-Blue Filter and Corneal Viewing Lens
    2. Welch Allyn PanOptic Ophthalmoscope
    3. Welch Allyn Suresight™ Vision Screener (English)
    4. Welch Allyn 2.5v PocketScope Ophthalmoscope with AA battery handle in soft carrying case
    5. Welch Allyn 2.5v PocketScope Ophthalmoscope with AA battery handle
    6. Welch Allyn 2.5v PocketScope Ophthalmoscope (without Handle)
    7. Welch Allyn Prestige Coaxial-plus Ophthalmoscope (Head Only)
    8. Welch Allyn Video Direct Ophthalmoscope (Head Only)
    9. Welch Allyn Binocular Indirect Ophthalmoscope with Diffuser Filter
    10. Welch Allyn 3.5v AutoStep Coaxial Ophthalmoscope Head Only
    11. PowerLab/4SP
    Breaking Medicine Technology:VidaySalud.com(TM) Reaches 1,000,000 Page Views In its First Six Months of Operation 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 7Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day 2Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day 3JAG Media Holdings Inc Amends Articles of Incorporation 58781 1JAG Media Holdings Inc Amends Articles of Incorporation 58781 2Vermillion Announces Return of Eric Fung M D Ph D 14338 1Vermillion Announces Return of Eric Fung M D Ph D 14338 2Vermillion Announces Return of Eric Fung M D Ph D 14338 3Hamon Tower Features Critical Care Advances Potential for Reduced Costs 5195 1Hamon Tower Features Critical Care Advances Potential for Reduced Costs 5195 2